Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interaction Between Meningococcal Serogroup B Vaccine (Bexsero™) and Routine Infant Vaccines on the Risk of Occurrence and Recurrence of Adverse Events Following Immunization.

NCT02712177 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT02712177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02712177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interaction Between Meningococcal Serogroup B Vaccine (Bexsero™) and Routine Infant Vaccines on the Risk of Occurrence and Recurrence of Adverse Events Following Immunization.
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
April 30, 2019
Enrollment
4,535 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal infections